Cargando…
Optimizing the first-line treatment for metastatic colorectal cancer
Colorectal cancer represents an important oncological challenge both for its incidence, which makes it an important health problem, and for its biological complexity, which has made clinical results very difficult in terms of outcome for this category of patients. To date these diseases should not b...
Autores principales: | Cherri, Sara, Oneda, Ester, Zanotti, Laura, Zaniboni, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614157/ https://www.ncbi.nlm.nih.gov/pubmed/37909027 http://dx.doi.org/10.3389/fonc.2023.1246716 |
Ejemplares similares
-
New drugs for the treatment of metastatic colorectal cancer
por: Cherri, Sara, et al.
Publicado: (2021) -
Microsatellite instability and chemosensitivity in solid tumours
por: Cherri, Sara, et al.
Publicado: (2022) -
Chemotherapy-induced neurotoxicity in the treatment of gynecological cancers: State of art and an innovative approach for prevention
por: Oneda, Ester, et al.
Publicado: (2021) -
Pancreatic adenocarcinoma: Beyond first line, where are we?
por: Cherri, Sara, et al.
Publicado: (2021) -
Are We Sure that Adjuvant Chemotherapy is the Best Approach for Resectable Pancreatic Cancer? Are We in the Era of Neoadjuvant Treatment? A Review of Current Literature
por: Oneda, Ester, et al.
Publicado: (2019)